506690 logo

Unichem Laboratories Stock Price

Symbol: BSE:506690Market Cap: ₹43.6bCategory: Pharmaceuticals & Biotech

506690 Share Price Performance

Community Fair Values

    Recent 506690 News & Updates

    No updates

    Unichem Laboratories Limited Key Details

    ₹21.1b

    Revenue

    ₹9.2b

    Cost of Revenue

    ₹11.9b

    Gross Profit

    ₹10.5b

    Other Expenses

    ₹1.4b

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    Aug 04, 2025
    Earnings per share (EPS)
    19.53
    Gross Margin
    56.33%
    Net Profit Margin
    6.51%
    Debt/Equity Ratio
    17.5%

    Unichem Laboratories Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 506690

    Founded
    1944
    Employees
    3142
    CEO
    Pabitra Kumar Bhattacharyya
    WebsiteView website
    www.unichemlabs.com

    Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited operates as a subsidiary of Ipca Laboratories Ltd.

    Indian Market Performance

    • 7 Days: -1.8%
    • 3 Months: 5.5%
    • 1 Year: -6.0%
    • Year to Date: -0.3%
    Over the last 7 days, the market has dropped 1.8%, driven by a loss of 2.7% in the Financials sector. In the last 12 months the market is down 6.0%. Earnings are forecast to grow by 15% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading